Protective effects of Xinji′erkang on myocardial infarction induced cardiac injury in mice

BACKGROUND: Myocardial infarction (MI) is a major risk factor responsible for morbidity and mortality. Xinji′erkang (XJEK) has been clinically used as an effective medication in the treatment of coronary heart disease and myocarditis. The purpose of this study was to investigate the cardioprotective...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Complement Altern Med
Hlavní autoři: Hu, Juan, Zhang, Yong-xue, Wang, Li, Ding, Ling, Huang, Guang-yao, Cai, Guo-wei, Gao, Shan
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5485507/
https://ncbi.nlm.nih.gov/pubmed/28651598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-017-1846-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky